These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 4695670)

  • 1. Potentiation of barbiturate hypnosis by 5-diazoimidazole-4-carboxamide and its derivatives.
    Morita K; Yamamoto I; Iwata H
    Biochem Pharmacol; 1973 May; 22(9):1115-8. PubMed ID: 4695670
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of 5-diazoimidazole-4-carboxamide and 3-diazopyrazole-4-carboxamide and related thioazo compounds on xanthine oxidase, uricase, and hypoxanthine-guanine phosphoriboxyltransferase.
    Iwata H; Yamamoto I; Gohda E; Morita E; Nishino K
    Biochem Pharmacol; 1972 Aug; 21(15):2141-4. PubMed ID: 4674940
    [No Abstract]   [Full Text] [Related]  

  • 3. Role of 4-diazoimidazole-5-carboxamide in the action of the antitumor agent 5(4)-(3,3-dimethyl-1-triazeno) imidazole-4-(5)carboxamide in Bacillus subtilis.
    Saunders PP; Schultz GA
    Biochem Pharmacol; 1972 Aug; 21(15):2065-76. PubMed ID: 4630320
    [No Abstract]   [Full Text] [Related]  

  • 4. Antigenic changes of L1210 leukemia in mice treated with 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide.
    Bonmassar E; Bonmassar A; Vadlamudi S; Goldin A
    Cancer Res; 1972 Jul; 32(7):1446-50. PubMed ID: 4402275
    [No Abstract]   [Full Text] [Related]  

  • 5. In vitro activation of monoamine oxidase in rat tissue homogenates by 4 (or 5)-diazoimidazole-5(or 4)-carboxamide.
    Yamamoto I; Oka M; Iwata H
    Biochem Pharmacol; 1970 May; 19(5):1831-3. PubMed ID: 5513964
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies on the mechanism of inhibition of xanthine oxidase by 5-diazoimidazole-4-carboxamide and related thioazoimidazole carboxamides.
    Iwata H; Yamamoto I; Gohda E
    Biochem Pharmacol; 1973 Aug; 22(15):1845-54. PubMed ID: 4722456
    [No Abstract]   [Full Text] [Related]  

  • 7. Potentiation of barbiturate hypnosis by probenecid: differential effect in tolerant animals.
    Lyness WH; Mycek MJ
    Neuropharmacology; 1981 Mar; 20(3):217-26. PubMed ID: 7266783
    [No Abstract]   [Full Text] [Related]  

  • 8. Imidazole derivatives--a new class of microsomal enzyme inhibitors.
    Wilkinson CF; Hetnarski K; Yellin TO
    Biochem Pharmacol; 1972 Dec; 21(23):3187-92. PubMed ID: 4650639
    [No Abstract]   [Full Text] [Related]  

  • 9. The potentiation of barbiturate-induced narcosis by procarbazine.
    Lee IP; Lucier GW
    J Pharmacol Exp Ther; 1976 Mar; 196(3):586-93. PubMed ID: 1263114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of methylchloroform inhalation on barbiturate hypnosis and hepatic drug metabolism in male mice.
    Lal H; Shah HC
    Toxicol Appl Pharmacol; 1970 Nov; 17(3):625-33. PubMed ID: 5528147
    [No Abstract]   [Full Text] [Related]  

  • 11. Interaction of the imidazolone derivative GPA 1851 with hepatic microsomal drug metabolism.
    Zak SB; Gilleran TG; Lukas G
    Pharmacology; 1972; 8(4):222-31. PubMed ID: 4633044
    [No Abstract]   [Full Text] [Related]  

  • 12. Mechanisms underlying potentiation of barbiturate action by sodium nitrite in the mouse: the role of methemoglobin-induced hypoxia.
    Baumel IP; Pitterman A; Patel G; DeFeo JJ; Lal H
    J Pharmacol Exp Ther; 1974 Feb; 188(2):481-9. PubMed ID: 4811305
    [No Abstract]   [Full Text] [Related]  

  • 13. [Preliminary pharmacological studies on 6 new derivatives of 5-phenylimidazoline].
    Kruszewska A; Langwiński R
    Ann Univ Mariae Curie Sklodowska Med; 1981; 36():111-7. PubMed ID: 7052757
    [No Abstract]   [Full Text] [Related]  

  • 14. [The central effects of 2 groups of newly synthesized barbiturates].
    Getova D
    Eksp Med Morfol; 1988; 27(2):17-24. PubMed ID: 3168904
    [No Abstract]   [Full Text] [Related]  

  • 15. Genetic control of barbiturate depression: strain and sex variation.
    Halevy S; Frumin MJ
    Br J Anaesth; 1973 Oct; 45(10):999-1004. PubMed ID: 4772652
    [No Abstract]   [Full Text] [Related]  

  • 16. [To the study of the mechanism of potentiation of hypnotic effect of hexenal by 3,5-dimethyl-4-brompyrazol].
    Avakumov VM; Batulin IuM
    Farmakol Toksikol; 1968; 31(4):402-5. PubMed ID: 5698126
    [No Abstract]   [Full Text] [Related]  

  • 17. The effects of 1-alkylimidazoles on hepatic drug-metabolizing enzyme activity.
    Palmer ED; Cawthorne MA
    Xenobiotica; 1974 Apr; 4(4):209-17. PubMed ID: 4847029
    [No Abstract]   [Full Text] [Related]  

  • 18. Studies on some possible mechanisms of potentiation of hexobarbital hypnosis by pilocarpine, muscarine and arecoline.
    Tsujimoto A; Doi T; Ikeda M; Nishikawa T
    Arch Int Pharmacodyn Ther; 1974 Dec; 212(2):264-73. PubMed ID: 4447408
    [No Abstract]   [Full Text] [Related]  

  • 19. The interaction of barbital and testosterone relative to their hypnotic effects.
    Gessner PK; Gessner T
    Arch Int Pharmacodyn Ther; 1973 Jan; 201(1):52-8. PubMed ID: 4717387
    [No Abstract]   [Full Text] [Related]  

  • 20. Biological activities of diazonium compounds: induction of hypothermia or writhing by 4 (or 5)-diazoimidazole-5 (or 4)-carboxamide and their antagonism by analgesics.
    Iwata H; Doi T; Yamamoto I
    Jpn J Pharmacol; 1970 Dec; 20(4):488-96. PubMed ID: 5312931
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.